www.nasdaq.com/de/symbol/vktx/real-time
|
Viking meldet Zahlen für 2018
ir.vikingtherapeutics.com/...lts-and-Provides-Corporate-Update
Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019
https://www.ariva.de/news/...sent-new-data-from-phase-2-study-7508084
|
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 112 | Viking Therapeutics Inc Skyrocker! | Balu4u | ARIVA.DE | 29.10.25 08:00 |